Abstract
β-receptor blockers are often considered as agents of first choice in antihypertensive therapy (Kewitz 1978). Side-effects are seldom, contraindications must be noted; in bronchial asthma, β-blockers are contraindicated (Burley 1975; Frishman 1979). We carried out a retrospective investigation of 100 randomly sampled hypertensive patients (bronchial asthma had not been noted in the history) treated with β-blockers and with clonidine. Airway resistance, chest complaints and history of respiratory diseases were compared and the incidence of bronchial side-effects by high-dose (e.g. antihypertensive) β-blocker therapy measured.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burley DM (1975) Therapiewoche 25: 4342–346
Frishman Wet al (1979) Am Heart J 98: 256–262
Kewitz H (1978) Medizinische und wirtschaftliche rationale Arzneimitteltherapie. Springer, Berlin
Waal-Manning HJ (1976) Drugs 12: 412–441
Williams JP, Millard FJC (1980) Thorax 35: 160
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Trauth, H.A. (1985). β-Blockers or Clonidine in Antihypertensive Therapy?. In: Weber, M.A., Drayer, J.I.M., Kolloch, R. (eds) Low Dose Oral and Transdermal Therapy of Hypertension. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-53785-1_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-53785-1_28
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-53787-5
Online ISBN: 978-3-642-53785-1
eBook Packages: Springer Book Archive